A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
REDWOOD-HCM Topline Results
Presentation
July 19, 2021
Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Rudnicki SA, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, et al
July 5, 2021
Efficacy of Omecamtiv Mecarbil in HFrEF According to NT-proBNP Level: Insights from the GALACTIC-HF Trial
Presentation, European Society of Cardiology Heart Failure 2021
McMurray, JJV, et al
Virtual
June 29, 2021
Omecamtiv Mecarbil in Patients with Severe Heart Failure: An Analysis from GALACTIC-HF
Presentation, European Society of Cardiology Heart Failure 2021
Felker, GM
Virtual
June 29, 2021
Influence of Atrial Fibrillation on Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure: The GALACTIC-HF Trial
Presentation, European Society of Cardiology Heart Failure 2021
Solomon SD
Virtual
June 29, 2021